AVROBIO Inc
NASDAQ:TECX
AVROBIO Inc
NASDAQ:TECX
Price:
30.52
USD
-0.84%
Market Cap:
$573.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
AVROBIO Inc
NASDAQ:TECX
|
US |
|
Masco Corp
NYSE:MAS
|
US |
|
Avance Gas Holding Ltd
OTC:AVACF
|
BM |
|
C
|
Capital Appreciation Ltd
JSE:CTA
|
ZA |
|
Entera Bio Ltd
NASDAQ:ENTX
|
IL |
|
CubicFarm Systems Corp
TSX:CUB
|
CA |
|
CapitaLand Ascott Trust
OTC:ATTRF
|
SG |
|
Logitech International SA
NASDAQ:LOGI
|
CH |
|
C
|
Cardinal Health Inc
XBER:CLH
|
US |
|
Arch Capital Group Ltd
NASDAQ:ACGL
|
BM |
|
M K Proteins Ltd
NSE:MKPL
|
IN |
|
FLEX LNG Ltd
OSE:FLNG
|
BM |
|
V
|
Vertu Capital Ltd
LSE:VCBC
|
MY |
|
D
|
Doms Industries Ltd
NSE:DOMS
|
IN |
|
M
|
Minor International PCL
SET:MINT
|
TH |
|
Middlefield Banc Corp
NASDAQ:MBCN
|
US |
|
I
|
Interwood Xylemboria ATENE
ATHEX:XYLEK
|
GR |
|
G
|
Greek Organisation of Football Prognostics SA
ATHEX:OPAP
|
GR |
|
H
|
Hong Leong Capital Bhd
KLSE:HLCAP
|
MY |
|
V
|
Valencia Capital Inc
XTSX:VAL.P
|
CA |
|
A
|
American CuMo Mining Corp
XTSX:MLY
|
CA |
|
Antilles Gold Ltd
ASX:AAU
|
AU |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of TECX.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TECX
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
TECX Competitors Multiples
AVROBIO Inc Competitors
AVROBIO Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
AVROBIO Inc
NASDAQ:TECX
|
571.9m USD | 0 | -7.7 | -3.8 | -3.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD | 6 | 88.2 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.4B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD | 9.3 | 28.2 | 21.2 | 22.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD | 5.6 | 17.9 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3.1 | 34 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.3 | 40.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
